Literature DB >> 5868429

[The sensitive phase in thalidomide embryopathy].

E Nowack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5868429     DOI： 10.1007/bf00338341

Source DB:  PubMed          Journal:  Humangenetik        ISSN： 0018-7348


× No keyword cloud information.
  8 in total

Review 1.  [CLINICAL OBSERVATIONS ON PHARMACOGENIC TERATOGENESIS].

Authors:  H R WIEDEMANN
Journal:  Bull Schweiz Akad Med Wiss       Date:  1964-09

2.  [Thalidomide embryopathy].

Authors:  F FARIZON; A MASBERNARD
Journal:  Presse Med       Date:  1962-10-20       Impact factor: 1.228

3.  [Ear abnormality, facial and abducent nerve paralysis as a syndrome of thalidomide injury].

Authors:  A MIEHLKE; C J PARTSCH
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1963

4.  Two cases of phocomelia in Finnish Lapland.

Authors:  I VAANANEN; T JOKI
Journal:  Ann Paediatr Fenn       Date:  1963

5.  [A teratogenic drug?].

Authors:  N ENGSTROM; B PERSSON; C THOREN
Journal:  Sven Lakartidn       Date:  1962-03-08

6.  Thalidomide embryopathy.

Authors:  W LENZ; K KNAPP
Journal:  Arch Environ Health       Date:  1962-08

7.  [Contribution to the teratological analysis of the new Wiedemann dysmelia syndrome (thalidomide abnormalities)].

Authors:  G PLIESS
Journal:  Med Klin       Date:  1962-09-14

8.  Drug-Induced (Thalidomide) Malformations.

Authors:  G M Ing; C L Olman; J R Oyd
Journal:  Can Med Assoc J       Date:  1962-12-15       Impact factor: 8.262
  8 in total
  16 in total

Review 1.  Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus.

Authors:  M T Miller
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Refractive evaluation in thalidomide embryopathy.

Authors:  K Strömland; M T Miller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 3.  What can we learn from the thalidomide experience: an ophthalmologic perspective.

Authors:  Marilyn T Miller; Kerstin K Strömland
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

4.  Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus. II. Elucidation of the susceptible period and of the variability of embryonic stages.

Authors:  D Neubert; W Heger; H J Merker; K Sames; R Meister
Journal:  Arch Toxicol       Date:  1988-01       Impact factor: 5.153

5.  Thalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells.

Authors:  Saoko Tachikawa; Toshinobu Nishimura; Hiromitsu Nakauchi; Kiyoshi Ohnuma
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-08-28       Impact factor: 2.416

6.  [Abnormalities in the field of otorhinolaryngology. Genetic report].

Authors:  G Jörgensen
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1972

7.  [Prognosis of the embryonic development state in humans].

Authors:  D von Kobyletzki; J Gellen
Journal:  Arch Gynakol       Date:  1970

8.  [Dysgnathias in the deciduous dentition in dysmelia: contribution to thalidomide embryopathy].

Authors:  A Stahl
Journal:  Fortschr Kieferorthop       Date:  1966

9.  Autism with ophthalmologic malformations: the plot thickens.

Authors:  Marilyn T Miller; Kerstin Strömland; Liana Ventura; Maria Johansson; Jose M Bandim; Christopher Gillberg
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Risk indicators of reduction limb defects.

Authors:  T Aro; O P Heinonen; L Saxén
Journal:  J Epidemiol Community Health       Date:  1983-03       Impact factor: 3.710
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.